查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1402014

2030 年合成生物学市场预测：按产品、技术、应用、最终用户和地区进行的全球分析

Synthetic Biology Market Forecasts to 2030 - Global Analysis By Product, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球合成生物学市场规模为 155 亿美元，预计在预测期内复合年增长率为 19%，到 2030 年将达到 526 亿美元。

合成生物学是生物学的一个先进领域，它利用现代科学来改造生物体，以改善医疗卫生服务的发展。其用途多种多样，包括细胞讯号传导、疫苗开发和抗体生产。这个过程涉及确定治疗各种疾病（包括感染疾病、免疫学和癌症疾病）的新治疗标靶所需的特定代谢途径。

根据 SynBioBeta资料，合成生物学新兴企业在 2021 年筹集了 180 亿美元。

扩大合成生物技术的应用

病原体、污染和气候危机造成的威胁日益严重，合成生物学研究和开发的资金不断增加。多个行业越来越多地采用合成生物学，旨在减少碳排放，防止全球气温进一步升高。这是因为该技术可以重现基本化学品和材料的特性，而不会对环境产生负面影响。因此，合成生物学的研究和开发变得更加活跃，其不断扩大的应用范围正在推动市场。

生物安全问题

有意或无意地将合成生物体释放到环境中（例如出于科学目的）是合成生物学中的主要生物安全风险。当合成微生物被引入大气中时，它们可能会突变并与现有物种相互作用，从而导致杂交和生物错误。这些后果可能会使野生动物栖息地面临风险。此外，对抗生素具有抗药性的病毒的出现对生物安全构成了严重威胁。这些限制可能会阻碍未来几年的市场扩张。

扩大医疗应用

在药物研发中，合成生物学透过自订製化生物电路加速治疗化合物的识别和开发。这不仅提高了药物开发的效率，也为创造更有效、更有针对性的药物铺平了道路。此外，合成生物学在生物製药的生产中发挥重要作用，使得工程利用微生物合成治疗性蛋白质和疫苗成为可能。这些不断增长的医学应用正在推动市场需求。

有限的可预测性

合成生物体和工程生物电路的行为通常是不可预测的，这给研究人员和开发人员带来了挑战。生物成分之间复杂的相互作用可能会导致意想不到的后果，例如出现意外行为或合成系统无法如预期发挥作用。然而，这种可预测性的缺乏阻碍了合成生物系统的有效设计和最佳化，导致时间和资源密集的试验误方法。因此，有限的可预测性是阻碍市场成长的关键因素。

COVID-19 的影响

在 COVID-19大流行期间，由于产量减少、停工和劳动力短缺，合成生物市场最初经历了成长略有放缓。然而，由于对 COVID-19 管理的新型疗法、疫苗和诊断方法的需求不断增加，该市场最终再次成长。药物开发和新冠疫苗研究支持了合成​​生物学研究。

底盘生物部分预计将在预测期内成为最大的部分

底盘生物部分估计占最大占有率。这些底盘生物提供了一个重要的生物框架，用于整合遗传电路和组件，以创造新的功能和改进的生物过程。诸如大肠桿菌的细菌和诸如酿酒酵母的酵母是经常使用的底盘生物体。选择这些生物体是因为它们的遗传背景易于理解、易于操作以及已建立的基因工程工具。底盘生物学领域的核心思想驱动着合成生物学的创新与发展。

PCR 技术领域预计在预测期内复合年增长率最高。

PCR 技术领域预计将在预测期内出现良好的成长。聚合酶炼式反应（PCR）已发展成为检测和分析特定基因序列的重要技术。对于大多数基于 PCR 的基因组研究，即时 PCR 检测因其卓越的灵敏度和特异性而成为首选方法。这种方法通常用于法医学分析、分子诊断、DNA 克隆和基因组学。

占有率最大的地区

在估计期间，北美占据了最大的市场占有率。世界上大多数在药物开发过程中使用合成生物学的公司和学术机构都位于北美。该地区运算能力、人工智慧和基因组图谱的进步使研究人员能够快速采用新技术并根据现有概念创建新功能。此外，数千名研究人员、科学家、学术机构、政府部门、私人投资者和产品工程师的合作正在透过新发现推动该地区的市场向前发展。

复合年增长率最高的地区：

预计亚太地区在预测期内将实现盈利成长。亚太地区投资的增加、中国市场的资金和合作伙伴关係的增加以及合成生物学领域合作的加强是预计推动市场成长的一些因素。此外，亚洲将在合成生物学应用开发新疗法方面发挥重要作用。亚洲各国政府和私人投资者对合成生物学研究和技术转移越来越感兴趣，该领域对于培育永续的生物经济有着巨大的前景。

免费客製化服务：

订阅此报告的客户可以利用以下免费自订选项之一：

  • 公司简介
    • 其他市场参与企业的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计/预测/复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 介绍
  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球合成生物市场：副产品

  • 介绍
  • 寡核苷酸
  • 酵素
  • 克隆技术套件
  • 合成DNA
  • 底盘生物学
  • 合成细胞
  • 异源核酸
  • 合成克隆
  • 其他产品

第六章全球合成生物市场：依技术分类

  • 介绍
  • 定点特异性
  • 奈米科技
  • 基因合成
  • 生物资讯学
  • 测量和建模
  • 基因组工程
  • 顺序
  • 新一代定序技术
  • 生物加工
  • 复製
  • PCR技术
  • 微流体学
  • 其他技术

第七章全球合成生物市场：依应用分类

  • 介绍
  • 医学
    • 药物研发与治疗
    • 药品
    • 人工组织和组织再生
  • 环境应用
    • 生物感
    • 生物修復
  • 工业用途
    • 工业酵素
    • 生物燃料和可再生能源
    • 生物材料和生态化学品
  • 在食品和农业的应用
    • 香精香料
  • 其他用途

第八章全球合成生物市场：依最终用户分类

  • 介绍
  • 学术研究所
  • 生物技术和製药业
  • 其他最终用户

第九章全球合成生物市场：按地区

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 中东和非洲其他地区

第10章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司简介

  • Synbio Technologies
  • GenScript
  • Agilent Technologies, Inc.
  • Eurofins Genomics GmbH
  • Thermo Fisher Scientific
  • Amyris
  • Merck KGaA
  • Codexis, Inc.
  • Integrated DNA Technologies, Inc.
  • Synthego
  • EnBiotix, Inc.
  • Genomatica, Inc.
  • 新英格兰生物实验室（英国）有限公司
  • Scarab Genomics, LLC
Product Code: SMRC24534

According to Stratistics MRC, the Global Synthetic Biology Market is accounted for $15.5 billion in 2023 and is expected to reach $52.6 billion by 2030 growing at a CAGR of 19% during the forecast period. Synthetic biology is an advanced field of biology that uses modern science to engineer organisms in order to improve the development of medical and health services. Its applications vary and include cellular signalling, vaccine development, and antibody production. The process includes specific metabolic pathways that are necessary for identifying novel therapeutic targets for the treatment of a variety of illnesses, including infectious, immunological, and cancerous diseases.

According to SynBioBeta data, startups within the synthetic biology sector raised 18.0 billion in 2021.

Market Dynamics:

Driver:

Rising applications of synthetic biotechnology

The funding for synthetic biology research and development has increased due to the growing threat posed by pathogens, pollution, and the climate change crisis. The adoption of synthetic biology has increased in several industries that aim to lower their carbon footprints in order to prevent further rises in global temperatures. This is due to the technology's ability to replicate the properties of essential chemicals and materials without causing negative environmental effects. Therefore, rising research and development in synthetic biology are widening the scope of its applications, which will drive the market.

Restraint:

Bio safety concerns

The intentional or unintentional release of synthetic organisms into the environment for scientific purposes or other purposes poses the main bio safety risk in synthetic biology. When synthetic microorganisms are put into the atmosphere, they can mutate or interact with existing species, resulting in crossbreeding and bio errors. These consequences may endanger the habitats of wild animals. Moreover, a serious threat to bio security is the emergence of viruses that are resistant to antibiotics. These limitations could hamper market expansion in the coming years.

Opportunity:

Expanding applications in healthcare

In drug discovery, synthetic biology accelerates the identification and development of therapeutic compounds by constructing custom biological circuits. This not only enhances the efficiency of drug development but also opens avenues for the creation of more effective and targeted pharmaceuticals. Additionally, synthetic biology plays a crucial role in biopharmaceutical production, enabling the engineering of microorganisms for the synthesis of therapeutic proteins and vaccines. These rising applications in healthcare propel market demand.

Threat:

Limited predictability

The behavior of synthetic organisms and engineered biological circuits often exhibits unpredictability, posing challenges for researchers and developers. The complex interplay of biological components can result in unintended consequences, such as the emergence of unexpected behaviours or the failure of synthetic systems to perform as intended. However, this lack of predictability hinders the efficient design and optimization of synthetic biological systems, leading to time-consuming and resource-intensive trial-and-error approaches. Therefore, limited predictability is a significant element hampering market growth.

COVID-19 Impact

The synthetic biology market saw a minor downturn in growth during the COVID-19 pandemic, at first because of a decrease in production, then lockdown and a labor shortage. However, the market eventually saw resurgence in growth because of the increased need for novel treatments, vaccines, and diagnostics for COVID-19 management. The development of medications and research on the COVID vaccine supported synthetic biology research.

The chassis organism segment is expected to be the largest during the forecast period

The chassis organism segment is estimated to hold the largest share. These chassis organisms provide the essential biological framework onto which genetic circuits and components can be integrated to create novel functionalities or modified biological processes. Bacteria like Escherichia coli and yeasts like Saccharomyces cerevisiae are frequently used chassis organisms. These organisms are selected for their well-understood genetic backgrounds, ease of manipulation, and established tools for genetic engineering. The field's core idea of chassis organisms promotes innovation and developments in synthetic biology.

The PCR technology segment is expected to have the highest CAGR during the forecast period

The PCR technology segment is anticipated to have lucrative growth during the forecast period. Polymerase Chain Reaction (PCR) has evolved as a crucial technology for detecting and analyzing specific gene sequences. For most PCR-based genomic research, real-time PCR tests are the preferred approach due to their exceptional sensitivity and specificity. This approach is commonly utilized in forensic analysis, molecular diagnostics, DNA cloning, and genomics.

Region with largest share:

North America commanded the largest market share during the extrapolated period. The majority of the world's businesses and academic institutions that use synthetic biology in their drug development processes are located in North America. Advances in computer power, artificial intelligence, and genome mapping in this region have prompted researchers to quickly embrace new methods and build upon pre-existing concepts to create new capacities. Additionally, the cooperation of thousands of researchers, scientists, academic institutions, government departments, private investors, and product engineers has advanced the market in this region with new discoveries.

Region with highest CAGR:

Asia Pacific is expected to witness profitable growth over the projection period. Increasing investments in the Asia-Pacific region, more funding and partnerships in the Chinese market, and more collaboration in the field of synthetic biology are some of the factors anticipated to propel market growth. Additionally, Asia is also well-positioned to play a significant role in the application of synthetic biology toward the development of novel therapeutics. Governments and private investors in Asia are becoming increasingly interested in synthetic biology research and technology translation, where the field holds enormous promise for fostering a sustainable bio-based economy.

Key players in the market:

Some of the key players in the Synthetic Biology Market include Synbio Technologies, GenScript, Agilent Technologies, Inc., Eurofins Genomics GmbH, Thermo Fisher Scientific, Amyris, Merck KGaA, Codexis, Inc., Integrated DNA Technologies, Inc., Synthego, EnBiotix, Inc., Genomatica, Inc., New England Biolabs (UK) Ltd. and Scarab Genomics, LLC.

Key Developments:

In April 2022, Merck KGaA Acquisition of MAST Platform from Lonza, a Leading Automated Bioreactor Sampling System. The acquisition of the MAST platform is another milestone to accelerate innovation in Merck's Process Solutions business unit.

In February 2022, Thermo Fisher Scientific announced the launch of GeneMapper Software, a flexible genotyping software package that provides DNA sizing and quality allele calls for all Thermo Fisher Scientific electrophoresis-based genotyping.

Products Covered:

  • Oligonucleotide
  • Enzymes
  • Cloning Technologies Kits
  • Synthetic DNA
  • Chassis Organism
  • Synthetic cells
  • Xeno-Nucleic Acids
  • Synthetic Clones
  • Other Products

Technologies Covered:

  • Site-Directed Mutagenesis
  • Nanotechnology
  • Gene Synthesis
  • Bioinformatics
  • Measurement and Modelling
  • Genome Engineering
  • Sequencing
  • NGS Technology
  • Bio processing
  • Cloning
  • PCR Technology
  • Microfluidics
  • Other Technologies

Applications Covered:

  • Medical
  • Environmental Applications
  • Industrial Applications
  • Food and Agricultural Applications
  • Other Applications

End Users Covered:

  • Academics & Research Institutes
  • Biotechnology & Pharmaceutical Industry
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Synthetic Biology Market, By Product

  • 5.1 Introduction
  • 5.2 Oligonucleotide
  • 5.3 Enzymes
  • 5.4 Cloning Technologies Kits
  • 5.5 Synthetic DNA
  • 5.6 Chassis Organism
  • 5.7 Synthetic cells
  • 5.8 Xeno-Nucleic Acids
  • 5.9 Synthetic Clones
  • 5.10 Other Products

6 Global Synthetic Biology Market, By Technology

  • 6.1 Introduction
  • 6.2 Site-Directed Mutagenesis
  • 6.3 Nanotechnology
  • 6.4 Gene Synthesis
  • 6.5 Bioinformatics
  • 6.6 Measurement and Modelling
  • 6.7 Genome Engineering
  • 6.8 Sequencing
  • 6.9 NGS Technology
  • 6.10 Bioprocessing
  • 6.11 Cloning
  • 6.12 PCR Technology
  • 6.13 Microfluidics
  • 6.14 Other Technologies

7 Global Synthetic Biology Market, By Application

  • 7.1 Introduction
  • 7.2 Medical
    • 7.2.1 Drug Discovery and Therapeutics
    • 7.2.2 Pharmaceuticals
    • 7.2.3 Artificial Tissue and Tissue Regeneration
  • 7.3 Environmental Applications
    • 7.3.1 Biosensing
    • 7.3.2 Bioremediation
  • 7.4 Industrial Applications
    • 7.4.1 Industrial Enzymes
    • 7.4.2 Biofuel and Renewable Energy
    • 7.4.3 Biomaterials and Green Chemicals
  • 7.5 Food and Agricultural Applications
    • 7.5.1 Flavors and Fragrances
  • 7.6 Other Applications

8 Global Synthetic Biology Market, By End user

  • 8.1 Introduction
  • 8.2 Academics & Research Institutes
  • 8.3 Biotechnology & Pharmaceutical Industry
  • 8.4 Other End Users

9 Global Synthetic Biology Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Synbio Technologies
  • 11.2 GenScript
  • 11.3 Agilent Technologies, Inc.
  • 11.4 Eurofins Genomics GmbH
  • 11.5 Thermo Fisher Scientific
  • 11.6 Amyris
  • 11.7 Merck KGaA
  • 11.8 Codexis, Inc.
  • 11.9 Integrated DNA Technologies, Inc.
  • 11.10 Synthego
  • 11.11 EnBiotix, Inc.
  • 11.12 Genomatica, Inc.
  • 11.13 New England Biolabs (UK) Ltd.
  • 11.14 Scarab Genomics, LLC

List of Tables

  • Table 1 Global Synthetic Biology Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Synthetic Biology Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Synthetic Biology Market Outlook, By Oligonucleotide (2021-2030) ($MN)
  • Table 4 Global Synthetic Biology Market Outlook, By Enzymes (2021-2030) ($MN)
  • Table 5 Global Synthetic Biology Market Outlook, By Cloning Technologies Kits (2021-2030) ($MN)
  • Table 6 Global Synthetic Biology Market Outlook, By Synthetic DNA (2021-2030) ($MN)
  • Table 7 Global Synthetic Biology Market Outlook, By Chassis Organism (2021-2030) ($MN)
  • Table 8 Global Synthetic Biology Market Outlook, By Synthetic cells (2021-2030) ($MN)
  • Table 9 Global Synthetic Biology Market Outlook, By Xeno-Nucleic Acids (2021-2030) ($MN)
  • Table 10 Global Synthetic Biology Market Outlook, By Synthetic Clones (2021-2030) ($MN)
  • Table 11 Global Synthetic Biology Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 12 Global Synthetic Biology Market Outlook, By Technology (2021-2030) ($MN)
  • Table 13 Global Synthetic Biology Market Outlook, By Site-Directed Mutagenesis (2021-2030) ($MN)
  • Table 14 Global Synthetic Biology Market Outlook, By Nanotechnology (2021-2030) ($MN)
  • Table 15 Global Synthetic Biology Market Outlook, By Gene Synthesis (2021-2030) ($MN)
  • Table 16 Global Synthetic Biology Market Outlook, By Bioinformatics (2021-2030) ($MN)
  • Table 17 Global Synthetic Biology Market Outlook, By Measurement and Modelling (2021-2030) ($MN)
  • Table 18 Global Synthetic Biology Market Outlook, By Genome Engineering (2021-2030) ($MN)
  • Table 19 Global Synthetic Biology Market Outlook, By Sequencing (2021-2030) ($MN)
  • Table 20 Global Synthetic Biology Market Outlook, By NGS Technology (2021-2030) ($MN)
  • Table 21 Global Synthetic Biology Market Outlook, By Bioprocessing (2021-2030) ($MN)
  • Table 22 Global Synthetic Biology Market Outlook, By Cloning (2021-2030) ($MN)
  • Table 23 Global Synthetic Biology Market Outlook, By PCR Technology (2021-2030) ($MN)
  • Table 24 Global Synthetic Biology Market Outlook, By Microfluidics (2021-2030) ($MN)
  • Table 25 Global Synthetic Biology Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 26 Global Synthetic Biology Market Outlook, By Application (2021-2030) ($MN)
  • Table 27 Global Synthetic Biology Market Outlook, By Medical (2021-2030) ($MN)
  • Table 28 Global Synthetic Biology Market Outlook, By Drug Discovery and Therapeutics (2021-2030) ($MN)
  • Table 29 Global Synthetic Biology Market Outlook, By Pharmaceuticals (2021-2030) ($MN)
  • Table 30 Global Synthetic Biology Market Outlook, By Artificial Tissue and Tissue Regeneration (2021-2030) ($MN)
  • Table 31 Global Synthetic Biology Market Outlook, By Environmental Applications (2021-2030) ($MN)
  • Table 32 Global Synthetic Biology Market Outlook, By Biosensing (2021-2030) ($MN)
  • Table 33 Global Synthetic Biology Market Outlook, By Bioremediation (2021-2030) ($MN)
  • Table 34 Global Synthetic Biology Market Outlook, By Industrial Applications (2021-2030) ($MN)
  • Table 35 Global Synthetic Biology Market Outlook, By Industrial Enzymes (2021-2030) ($MN)
  • Table 36 Global Synthetic Biology Market Outlook, By Biofuel and Renewable Energy (2021-2030) ($MN)
  • Table 37 Global Synthetic Biology Market Outlook, By Biomaterials and Green Chemicals (2021-2030) ($MN)
  • Table 38 Global Synthetic Biology Market Outlook, By Food and Agricultural Applications (2021-2030) ($MN)
  • Table 39 Global Synthetic Biology Market Outlook, By Flavors and Fragrances (2021-2030) ($MN)
  • Table 40 Global Synthetic Biology Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 41 Global Synthetic Biology Market Outlook, By End user (2021-2030) ($MN)
  • Table 42 Global Synthetic Biology Market Outlook, By Academics & Research Institutes (2021-2030) ($MN)
  • Table 43 Global Synthetic Biology Market Outlook, By Biotechnology & Pharmaceutical Industry (2021-2030) ($MN)
  • Table 44 Global Synthetic Biology Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.